Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitsui & Co.
Tokyo, Japan
- Ownership
- Private
- Employees
- ~46000
- Development stage
- Other
01
Overview
Mitsui & Co. provides global pharma and healthcare services, including AI-driven drug discovery (Tokyo-1 with NVIDIA), procurement, CDMO, investments in biopharma startups, and hospital/healthcare assets. Clinical-stage activities are via portfolio companies and partnerships, not under the Mitsui brand itself.
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateBiologicMedical deviceArtificial intelligence solutionsCDMO services
- Industry
- Investors
02
Partnerships
NVIDIA (AI drug discovery, Tokyo-1)Japanese pharma companies (CDMO, digital health)Biotech and diagnostic startupsMajor international pharma for licensing deals
Beyond the preview
Go deeper on Mitsui & Co..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitsui & Co..